Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB:
SEC Accession No. 0001144204-19-025287
Filing Date
2019-05-10
Accepted
2019-05-10 16:30:28
Documents
1
Period of Report
2019-03-31
Effectiveness Date
2019-05-10

Document Format Files

Seq Description Document Type Size
1 NT 10-Q tv520629_nt10q.htm NT 10-Q 25213
  Complete submission text file 0001144204-19-025287.txt   26382
Mailing Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850
Business Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850 240-864-2600
CASI Pharmaceuticals, Inc. (Filer) CIK: 0000895051 (see all company filings)

IRS No.: 581959440 | State of Incorp.: DE | Fiscal Year End: 1231
Type: NT 10-Q | Act: 34 | File No.: 000-20713 | Film No.: 19815404
SIC: 2836 Biological Products, (No Diagnostic Substances)